<DOC>
	<DOCNO>NCT01500512</DOCNO>
	<brief_summary>This research trial study patient early-stage vulvar cancer undergo sentinel lymph node dissection . Sentinel lymph node dissection may fewer side effect remove lymph node . Observing patient undergoing sentinel lymph node dissection may help doctor confirm safety procedure .</brief_summary>
	<brief_title>Observation Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To prospectively observe patient receive radiation +/- chemotherapy immediately lymph node dissection confirm safety procedure . OUTLINE : Patients receive standard therapy include sentinel lymph node dissection . Patients observe collect information treatment outcomes every 2 month 2 year .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<criteria>Patients must squamous cell carcinoma depth invasion &gt; 1 mm Patients must T1 T2 tumor ( International Federation Gynecology Obstetrics [ FIGO ] stag ) , &lt; 4 cm , encroach urethra , vagina , anus clinically negative inguinofemoral lymph node Localization size tumor perilesional injection tracer three four site possible Preoperative imaging show enlarge ( &lt; 1.5 cm ) suspicious nodes Patients must sign informed consent Inoperable tumor diameter &gt; 4 cm Patients inguinofemoral lymph node , palpation clinically suspect metastasis , radiology enlarge ( &gt; 1.5 cm ) suspicious groin node cytologically proven inguinofemoral lymph node metastases Patients multifocal tumor Patients currently investigational drug treatment vulvar cancer exclude participation trial</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>